Last update 01 Nov 2024

Saison Pharmaceutical R&D (Shanghai) Co., Ltd.

Private Company|
2015|
Shanghai Shi, China

Overview

Tags

Hemic and Lymphatic Diseases
Digestive System Disorders
Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
DNA1

Related

1
Drugs associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
PT-112
Target
DNA
Mechanism
DNA inhibitors
Active Org.
SciClone Pharmaceuticals International (Cayman) Development Limited [+5]
Originator Org.
Promontory Therapeutics, Inc.Promontory Therapeutics, Inc.
Active Indication
thymic carcinoma [+5]
Inactive Indication
Multiple Myeloma [+2]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
CTR20190817 / RecruitingPhase 1/2
一项PT-112联合吉西他滨注射液治疗晚期实体瘤患者的开放性I/II期临床研究
[Translation] An open-label phase I/II clinical study of PT-112 combined with gemcitabine injection in patients with advanced solid tumors
100 Clinical Results associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
Login to view more data
100 Deals associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Saison Pharmaceutical R&D (Shanghai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
PT-112
 ( DNA )		Advanced Malignant Solid Neoplasm
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free